No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1hnvB_, 1.0000, 0.00, 1.000, 427, 427, STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
2, d1uwbB_, 0.9957, 0.49, 0.998, 427, 427, TYR 181 CYS HIV-1 RT/8-CL TIBO
3, d1tvrB_, 0.9894, 0.78, 1.000, 427, 427, HIV-1 RT/9-CL TIBO
4, d2b6aB_, 0.9850, 0.89, 0.988, 427, 426, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
5, d2banB_, 0.9817, 1.08, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
6, d1hniB_, 0.9800, 1.14, 0.981, 427, 426, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
7, d2b5jB_, 0.9798, 1.14, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
8, d1s6qB_, 0.9790, 1.17, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
9, d1s6pB_, 0.9790, 1.15, 1.000, 427, 427, CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
10, d1s9eB_, 0.9780, 1.19, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
11, d1suqB_, 0.9771, 1.30, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
12, d1s9gB_, 0.9757, 1.12, 1.000, 425, 425, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
13, d4h4mB_, 0.9752, 1.28, 0.995, 428, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
14, d4h4oB_, 0.9746, 1.30, 0.995, 428, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH (E)-3-(3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)- 4- FLUOROPHENOXY)-5-FLUOROPHENYL)ACRYLONITRILE (JLJ506) A NON- NUCLEOSIDE INHIBITOR
15, d4o44B_, 0.9715, 1.40, 1.000, 427, 427, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-6-(3-MORPHOLINOPROPOXY)-135-TRIAZIN-2-YL)AMINO) BENZONITRILE (JLJ529) A NON-NUCLEOSIDE INHIBITOR
16, d1bqnB_, 0.9710, 1.55, 0.979, 430, 426, TYR 188 LEU HIV-1 RT/HBY 097
17, d1bqmB_, 0.9706, 1.57, 0.986, 430, 426, HIV-1 RT/HBY 097
18, d1hpzB_, 0.9701, 1.68, 0.998, 430, 427, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
19, d1hquB_, 0.9698, 1.41, 0.998, 430, 425, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
20, d1sv5B_, 0.9642, 1.48, 0.998, 427, 424, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
21, d4lslB_, 0.9536, 1.18, 0.983, 417, 416, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ476) A NON-NUCLEOSIDE INHIBITOR
22, d2be2B_, 0.9524, 1.60, 0.976, 426, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
23, d2i5jB_, 0.9517, 1.41, 0.995, 420, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH AN RNASE H INHIBITOR
24, d4rw8B_, 0.9511, 1.19, 0.990, 415, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR 
25, d1ikxB_, 0.9505, 2.05, 0.960, 427, 426, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721
26, d4lsnB_, 0.9479, 1.27, 0.986, 416, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-BROMO-5-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ518) A NON-NUCLEOSIDE INHIBITOR
27, d2ic3B_, 0.9472, 2.07, 0.976, 427, 424, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
28, d4mfbB_, 0.9424, 1.27, 0.988, 413, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY) INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
29, d5hbmB_, 0.9414, 1.27, 0.973, 413, 412, CRYSTAL STRUCTURE OF A DIHYDROXYCOUMARIN RNASE H ACTIVE-SITE INHIBITOR IN COMPLEX WITH HIV-1 REVERSE TRANSCRIPTASE
30, d1tv6B1, 0.9413, 1.13, 0.993, 411, 410, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94707
31, d5tw3B_, 0.9380, 1.07, 0.985, 409, 408, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)-4-FLUOROPHENOXY)- 7-FLUORO-2-NAPHTHONITRILE (JLJ636) A NON-NUCLEOSIDE INHIBITOR
32, d2ze2B_, 0.9363, 1.68, 0.961, 416, 414, CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
33, d5tepB_, 0.9344, 1.04, 0.985, 407, 406, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ649) A NON-NUCLEOSIDE INHIBITOR
34, d4o4gB_, 0.9331, 1.65, 0.959, 428, 414, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-135-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ527) A NON-NUCLEOSIDE INHIBITOR
35, d2jleB_, 0.9330, 1.50, 0.976, 415, 413, NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
36, d3kliB_, 0.9323, 2.11, 0.958, 427, 424, CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
37, d4pwdD_, 0.9318, 1.46, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
38, d1n5yB_, 0.9304, 2.23, 0.995, 429, 427, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
39, d4puoD_, 0.9302, 1.50, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
40, d1t03B_, 0.9301, 2.23, 0.995, 429, 427, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
41, d1n6qB_, 0.9299, 2.23, 0.995, 429, 427, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
42, d4dg1B_, 0.9298, 1.94, 0.971, 418, 416, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A
43, d1rtjB1, 0.9296, 1.58, 0.961, 417, 412, MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
44, d3is9B_, 0.9294, 1.90, 0.986, 416, 415, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 33 -(6-METHOXY-6-OXOHEX-1-ENE-11- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
45, d2yngB_, 0.9294, 1.60, 0.973, 411, 410, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK560
46, d4puoB_, 0.9291, 1.53, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
47, d1r0aB1, 0.9289, 2.20, 0.965, 429, 426, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
48, d2yknB_, 0.9288, 1.53, 0.980, 410, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
49, d1rtdB_, 0.9284, 1.60, 0.978, 414, 412, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
50, d4pwdB_, 0.9278, 1.56, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
51, d2wonB_, 0.9278, 1.47, 0.968, 412, 410, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
52, d3irxB_, 0.9277, 1.92, 0.983, 416, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(37-DIMETHYL-2-OXO-23-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-134-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
53, d1rthB1, 0.9258, 1.51, 0.966, 413, 409, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
54, d1vruB_, 0.9256, 1.47, 0.961, 410, 408, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
55, d3bgrB_, 0.9250, 1.62, 0.968, 412, 410, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
56, d5c24B_, 0.9249, 1.62, 0.968, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-68- DIMETHYLINDOLIZINE-2-CARBONITRILE (JLJ605) A NON-NUCLEOSIDE INHIBITOR
57, d4kkoB_, 0.9249, 1.62, 0.961, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-METHOXY-6-(2-MORPHOLINOETHOXY)-135-TRIAZIN-2-YL)AMINO)-2-((3- METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513) A NON-NUCLEOSIDE INHIBITOR
58, d4i2qB_, 0.9249, 1.72, 0.966, 416, 412, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE
59, d1t05B_, 0.9249, 1.67, 0.981, 414, 412, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
60, d4ig0B_, 0.9248, 1.72, 0.959, 416, 412, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 507 SITE
61, d4i2pB_, 0.9248, 1.61, 0.961, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE
62, d1dttB_, 0.9248, 1.39, 0.966, 412, 407, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 2 (PETT130A94)
63, d3ithB_, 0.9247, 1.75, 0.973, 415, 414, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
64, d1j5oB_, 0.9247, 2.31, 0.972, 430, 426, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
65, d1revB_, 0.9246, 1.73, 0.961, 412, 410, HIV-1 REVERSE TRANSCRIPTASE
66, d5cyqB_, 0.9242, 1.71, 0.966, 415, 412, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-BROMOPYRAZOLE
67, d1rtdD_, 0.9241, 1.69, 0.978, 414, 412, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
68, d4ig3B_, 0.9236, 1.74, 0.966, 416, 412, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT NEAR KNUCKLES SITE
69, d2ynhB_, 0.9236, 1.37, 0.973, 406, 405, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK500
70, d3ithD_, 0.9234, 1.85, 0.983, 415, 415, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
71, d2zd1B_, 0.9230, 1.66, 0.968, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
72, d2ynfB_, 0.9228, 1.39, 0.970, 406, 405, HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR GSK560
73, d2ykmB_, 0.9228, 1.66, 0.983, 410, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
74, d4g1qB_, 0.9227, 1.75, 0.966, 416, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278 EDURANT) A NON-NUCLEOSIDE RT-INHIBITING DRUG
75, d2rf2B_, 0.9226, 1.25, 0.983, 405, 404, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
76, d3dlkB_, 0.9222, 1.52, 0.971, 409, 408, CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE RT69A
77, d3qo9B_, 0.9219, 1.81, 0.966, 412, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
78, d4iclB_, 0.9218, 1.68, 0.971, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE INCOMING DNTP BINDING SITE
79, d4ifyB_, 0.9216, 1.67, 0.956, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE KNUCKLES SITE
80, d1ikwB_, 0.9215, 1.34, 0.980, 405, 405, WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ
81, d1c1bB_, 0.9215, 1.41, 0.966, 415, 406, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA- 186
82, d4ifvB_, 0.9210, 1.69, 0.963, 412, 410, DETECTING ALLOSTERIC SITES OF HIV-1 REVERSE TRANSCRIPTASE BY X-RAY CRYSTALLOGRAPHIC FRAGMENT SCREENING
83, d4idkB_, 0.9210, 1.68, 0.971, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 428 SITE
84, d2hmiB_, 0.9209, 2.35, 0.955, 430, 425, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
85, d4id5B_, 0.9203, 1.71, 0.971, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE RNASE H PRIMER GRIP SITE
86, d1qe1B_, 0.9203, 1.85, 0.961, 415, 414, CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
87, d4pquB_, 0.9199, 1.73, 0.983, 412, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
88, d1ikyB_, 0.9198, 1.38, 0.978, 405, 405, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194
89, d4kfbB_, 0.9192, 1.72, 0.963, 412, 410, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT NNRTI ADJACENT SITE
90, d4i7gB_, 0.9192, 1.72, 0.963, 412, 410,  
91, d3qlhB_, 0.9192, 1.53, 0.973, 407, 406, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
92, d3isnD_, 0.9191, 1.85, 0.964, 415, 414, CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
93, d3i0sB_, 0.9190, 1.34, 0.978, 405, 404, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7
94, d1ikvB_, 0.9190, 1.34, 0.985, 404, 404, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ
95, d2yniB_, 0.9184, 1.39, 0.973, 404, 403, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK952
96, d1hysB_, 0.9178, 2.37, 0.974, 425, 424, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
97, d3i0rB_, 0.9177, 1.36, 0.980, 405, 404, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3
98, d3drrB_, 0.9176, 1.32, 0.980, 404, 403, HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
99, d3c6uB_, 0.9175, 1.32, 0.983, 404, 403, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22
100, d3ig1B_, 0.9171, 1.69, 0.968, 409, 408, HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
101, d3c6tB_, 0.9171, 1.32, 0.983, 404, 403, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14
102, d1rtiB1, 0.9169, 1.36, 0.965, 407, 403, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
103, d5vqsB_, 0.9165, 1.30, 0.975, 403, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON- NUCLEOSIDE INHIBITOR
104, d3drpB_, 0.9165, 1.34, 0.983, 404, 403, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
105, d4we1B_, 0.9161, 1.25, 0.980, 402, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ600)
106, d4kv8B_, 0.9157, 1.60, 0.980, 407, 406, CRYSTAL STRUCTURE OF HIV RT IN COMPLEX WITH BILR0355BS
107, d1lw2B_, 0.9155, 1.54, 0.960, 406, 404, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
108, d5c25B_, 0.9153, 1.54, 0.978, 406, 405, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 6- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-57-DIMETHYL-2- NAPHTHONITRILE (JLJ639) A NON-NUCLEOSIDE INHIBITOR
109, d4ko0B_, 0.9153, 1.67, 0.971, 410, 407, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135)
110, d1dloB_, 0.9152, 1.90, 0.947, 415, 413, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
111, d3drsB_, 0.9149, 1.43, 0.980, 405, 404, HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
112, d1s1tB_, 0.9149, 1.42, 0.968, 416, 403, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
113, d1jlqB_, 0.9148, 1.42, 0.970, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
114, d5cymB_, 0.9144, 1.61, 0.975, 408, 406, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-IODOPYRAZOLE
115, d1c1cB_, 0.9141, 1.45, 0.970, 416, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK- 6123
116, d1fkoB_, 0.9139, 1.40, 0.975, 403, 402, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
117, d3megB_, 0.9136, 1.34, 0.975, 404, 402, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
118, d1fk9B_, 0.9133, 1.43, 0.960, 403, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP- 266(EFAVIRENZ)
119, d4i7fB_, 0.9132, 1.43, 0.975, 405, 403, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE
120, d1s1wB1, 0.9132, 1.52, 0.963, 404, 403, CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
121, d4rw4B_, 0.9128, 1.52, 0.980, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103NY181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
122, d1lwcB_, 0.9124, 1.41, 0.973, 402, 401, CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
123, d5tuqB_, 0.9120, 1.58, 0.975, 405, 404, CRYSTAL STRUCTURE OF A 6-CYCLOHEXYLMETHYL-3-HYDROXYPYRIMIDINE-24- DIONE INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
124, d1jlbB_, 0.9118, 1.38, 0.970, 405, 401, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
125, d1vrtB_, 0.9114, 1.35, 0.975, 401, 400, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
126, d2iajB_, 0.9112, 1.92, 0.922, 415, 412, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
127, d4rw7B_, 0.9110, 1.55, 0.978, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR
128, d4rw9B_, 0.9109, 1.56, 0.978, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON- NUCLEOSIDE INHIBITOR
129, d1rt5B_, 0.9108, 1.41, 0.973, 406, 401, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
130, d1rt7B1, 0.9104, 1.48, 0.973, 406, 402, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
131, d2vg5B_, 0.9102, 1.34, 0.972, 401, 400, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
132, d4pquD_, 0.9101, 2.00, 0.988, 413, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
133, d4rw6B_, 0.9100, 1.58, 0.978, 405, 403, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
134, d1s1uB1, 0.9095, 1.42, 0.962, 401, 400, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
135, d1rt1B1, 0.9094, 1.50, 0.970, 406, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
136, d1jleB_, 0.9094, 1.44, 0.978, 408, 401, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
137, d3tamB_, 0.9093, 1.46, 0.980, 403, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M06
138, d3lp1B_, 0.9093, 1.30, 0.977, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
139, d5vquB_, 0.9089, 1.42, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N- METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
140, d3kk2B_, 0.9089, 1.91, 0.978, 414, 411, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
141, d5vqvB_, 0.9088, 1.42, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
142, d5vqzB_, 0.9085, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
143, d5vqyB_, 0.9085, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
144, d1tkzB1, 0.9085, 1.45, 0.967, 400, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576
145, d1rt6B1, 0.9085, 1.47, 0.970, 405, 401, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
146, d5vqxB_, 0.9084, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
147, d5vqwB_, 0.9082, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON-NUCLEOSIDE INHIBITOR
148, d3meeB_, 0.9081, 1.31, 0.982, 401, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
149, d1tl3B1, 0.9081, 1.46, 0.967, 400, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
150, d5terB_, 0.9080, 1.43, 0.985, 401, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5- CHLORO-7-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-8-METHYL-2-NAPHTHONITRILE (JLJ651) A NON-NUCLEOSIDE INHIBITOR
151, d2vg6B_, 0.9080, 1.41, 0.970, 401, 400, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
152, d2hnyB_, 0.9080, 1.47, 0.962, 401, 400, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
153, d3dyaB_, 0.9078, 1.53, 0.970, 402, 401, HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1
154, d1c0uB_, 0.9076, 1.49, 0.973, 414, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934
155, d4zhrB_, 0.9075, 1.83, 0.941, 409, 408, STRUCTURE OF HIV-1 RT Q151M MUTANT
156, d3ffiB_, 0.9075, 1.60, 0.970, 403, 402, HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR
157, d1dtqB_, 0.9072, 1.55, 0.983, 402, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 1 (PETT131A94)
158, d5k14B_, 0.9070, 1.34, 0.982, 401, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 26-DIFLUOROPHENYL DAPY ANALOG
159, d3qipB_, 0.9069, 1.35, 0.980, 402, 399, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE
160, d5vqtB_, 0.9068, 1.41, 0.985, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 2- CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
161, d2oppB_, 0.9068, 1.44, 0.962, 403, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
162, d1lw0B_, 0.9068, 1.38, 0.972, 399, 398, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
163, d5vqrB_, 0.9067, 1.42, 0.985, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON- NUCLEOSIDE INHIBITOR
164, d5vqqB_, 0.9064, 1.42, 0.985, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N-METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
165, d3dolB_, 0.9064, 1.50, 0.968, 405, 401, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
166, d1tktB1, 0.9064, 1.45, 0.970, 399, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
167, d4ncgB_, 0.9062, 1.36, 0.980, 402, 399, DISCOVERY OF DORAVIRINE AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES
168, d2opqB_, 0.9061, 1.45, 0.965, 400, 399, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
169, d1eetB_, 0.9061, 1.39, 0.987, 399, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
170, d3m8pB_, 0.9060, 1.50, 0.972, 401, 400, HIV-1 RT WITH NNRTI TMC-125
171, d3mecB_, 0.9059, 1.37, 0.980, 401, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
172, d2rkiB_, 0.9054, 1.45, 0.977, 402, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
173, d3medB_, 0.9052, 1.39, 0.977, 401, 399, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
174, d1rt3B_, 0.9051, 1.29, 0.967, 398, 397, AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
175, d2hnzB_, 0.9050, 1.41, 0.965, 399, 398, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
176, d1klmB_, 0.9048, 1.44, 0.967, 405, 399, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
177, d1jlfB_, 0.9042, 1.46, 0.975, 404, 399, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
178, d1fkpB_, 0.9040, 1.35, 0.975, 408, 397, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
179, d3t1aB_, 0.9039, 1.42, 0.977, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05
180, d3lp2B_, 0.9039, 1.42, 0.977, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
181, d3lp0B_, 0.9039, 1.43, 0.977, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
182, d1jlgB_, 0.9038, 1.47, 0.972, 405, 399, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
183, d1rt4B_, 0.9033, 1.42, 0.980, 404, 398, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781
184, d3dokB_, 0.9030, 1.42, 0.965, 402, 398, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
185, d1lweB_, 0.9029, 1.54, 0.967, 401, 400, CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
186, d3kk1B_, 0.9027, 1.95, 0.980, 412, 409, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
187, d3di6B_, 0.9026, 1.45, 0.977, 400, 399, HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
188, d1hqeB_, 0.9024, 2.03, 0.963, 415, 409, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
189, d1tl1B1, 0.9021, 1.43, 0.967, 397, 397, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
190, d1jlcB_, 0.9017, 1.40, 0.972, 402, 397, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
191, d3dleB_, 0.9015, 1.46, 0.980, 403, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590.
192, d3t19B_, 0.9009, 1.50, 0.980, 400, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05
193, d1hvuK_, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
194, d1hvuH_, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
195, d1hvuE_, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
196, d1hvuB_, 0.9009, 1.43, 0.935, 400, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
197, d1ep4B_, 0.9009, 1.30, 0.972, 395, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- 1153
198, d3nbpB_, 0.9007, 1.60, 0.962, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
199, d5fdlB_, 0.9005, 1.27, 0.965, 396, 395, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH IDX899
200, d3e01B_, 0.9002, 1.67, 0.972, 401, 400, HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
201, d1s1xB1, 0.8992, 1.38, 0.962, 397, 396, CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
202, d2oprB_, 0.8986, 1.43, 0.977, 400, 396, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
203, d1jkhB_, 0.8986, 1.48, 0.972, 398, 397, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
204, d1jlaB_, 0.8980, 1.38, 0.975, 408, 395, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
205, d2vg7B_, 0.8979, 1.30, 0.980, 395, 394, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
206, d2hndB_, 0.8979, 1.24, 0.967, 394, 393, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
207, d3kk3B_, 0.8978, 1.80, 0.955, 407, 404, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
208, d3m8qB_, 0.8973, 1.57, 0.965, 398, 397, HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
209, d2opsB_, 0.8971, 1.46, 0.977, 409, 396, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
210, d3hvtB_, 0.8969, 1.48, 0.937, 398, 396, STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
211, d1rt2B_, 0.8964, 1.54, 0.972, 402, 397, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
212, d1s1vB1, 0.8961, 1.42, 0.975, 397, 395, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
213, d1tkxB1, 0.8949, 1.48, 0.982, 395, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
214, d5j1eB1, 0.8940, 1.94, 0.953, 404, 404, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
215, d1lwfB_, 0.8937, 1.45, 0.970, 395, 394, CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
216, d5uv5B1, 0.8908, 1.78, 0.952, 399, 399, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
217, d3dmjB_, 0.8892, 1.38, 0.972, 401, 391, CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
218, d3dm2B_, 0.8869, 1.38, 0.977, 400, 390, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
219, d3dlgB_, 0.8868, 1.38, 0.979, 400, 390, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
220, d1hmvH_, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
221, d1hmvF_, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
222, d1hmvD_, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
223, d1hmvB_, 0.8858, 1.58, 0.975, 395, 394, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
224, d3kjvB_, 0.8839, 1.74, 0.980, 400, 396, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
225, d5uv5D_, 0.8826, 1.63, 0.990, 393, 393, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
226, d5j1eD_, 0.8812, 1.65, 0.987, 393, 393, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
227, d1mu2B_, 0.8520, 2.46, 0.559, 402, 397, CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE
228, d1c0tB_, 0.8486, 1.33, 0.981, 373, 372, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326
229, d4kseB_, 0.7373, 2.17, 0.943, 401, 332, CRYSTAL STRUCTURE OF A HIV P51 (219-230) DELETION MUTANT
230, p3v81B1, 0.5480, 1.35, 0.975, 241, 241, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
231, p3klhB1, 0.5290, 1.74, 0.953, 238, 236, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
232, p5xn2D1, 0.5215, 1.86, 0.932, 237, 235, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
233, p3kleJ1, 0.5169, 1.40, 0.952, 227, 227, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
234, p3kleN1, 0.5167, 1.39, 0.952, 227, 227, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
235, p3kleB1, 0.5149, 1.50, 0.952, 227, 227, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
236, p3kleF1, 0.5145, 1.53, 0.952, 227, 227, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
237, p2womB1, 0.5103, 0.92, 0.950, 221, 221, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
238, p5txmD1, 0.5096, 1.10, 0.977, 222, 222, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
239, p5txlD1, 0.5096, 1.10, 0.977, 222, 222, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
240, p5txpD1, 0.5093, 1.12, 0.977, 222, 222, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
241, p4r5pD1, 0.5093, 1.12, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
242, p5txnD1, 0.5092, 1.13, 0.977, 222, 222, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
243, p5txoD1, 0.5090, 1.14, 0.977, 222, 222, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
244, p3v4iD1, 0.5090, 1.14, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
245, p5hroD1, 0.5089, 1.14, 0.977, 222, 222, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
246, p4q0bD1, 0.5088, 1.14, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
247, p3v6dD1, 0.5088, 1.14, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
248, p3klfF1, 0.5085, 1.17, 0.973, 222, 222, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
249, p3klfB1, 0.5084, 1.17, 0.973, 222, 222, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
250, p5i42D1, 0.5083, 1.18, 0.977, 222, 222, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
251, p3v81D1, 0.5083, 1.17, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
252, p5txpB1, 0.5078, 1.20, 0.977, 222, 222, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
253, p3v6dB1, 0.5078, 1.21, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
254, p4r5pB1, 0.5076, 1.22, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
255, p3v4iB1, 0.5076, 1.21, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
256, p5txoB1, 0.5075, 1.22, 0.977, 222, 222, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
257, p5txnB1, 0.5075, 1.22, 0.977, 222, 222, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
258, p5i42B1, 0.5074, 1.23, 0.977, 222, 222, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
259, p5hroB1, 0.5073, 1.24, 0.977, 222, 222, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
260, p4q0bB1, 0.5073, 1.21, 0.977, 222, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
261, p5i3uB1, 0.5072, 1.61, 0.955, 226, 224, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
262, p5hp1B1, 0.5071, 1.61, 0.955, 226, 224, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
263, p3jsmB1, 0.5070, 1.39, 0.969, 223, 223, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
264, p5d3gB1, 0.5068, 1.64, 0.955, 225, 224, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
265, p5hlfB1, 0.5065, 1.65, 0.955, 226, 224, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
266, p3jytB1, 0.5060, 1.45, 0.978, 223, 223, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS- DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
267, p3klgF1, 0.5054, 1.33, 0.977, 222, 222, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
268, p3klfN1, 0.5054, 1.51, 0.973, 223, 223, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
269, p5txmB1, 0.5052, 1.22, 0.977, 221, 221, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
270, p5txlB1, 0.5050, 1.24, 0.977, 221, 221, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
271, p3klgB1, 0.5048, 1.36, 0.977, 222, 222, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
272, p3klfJ1, 0.5029, 1.52, 0.973, 222, 222, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
273, p6eliB1, 0.5026, 1.65, 0.946, 226, 223, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE AND AN RNASE H INHIBITOR XZ462 
274, p6c0jB1, 0.5026, 1.70, 0.937, 224, 223, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR K-5A2 
275, p6c0lB1, 0.5023, 1.71, 0.933, 224, 223, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
276, p6cgfB1, 0.5022, 1.72, 0.937, 224, 223, CRYSTAL STRUCTURE OF HIV-1 Y188L MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
277, p5i3uD1, 0.5019, 1.38, 0.950, 221, 220, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
278, p5hp1D1, 0.5019, 1.38, 0.950, 221, 220, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
279, p6dufB1, 0.5018, 1.39, 0.945, 221, 220, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE V106A/F227L MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
280, p6dugB1, 0.5015, 1.36, 0.955, 221, 220, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE K101P MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
281, p6c0rB1, 0.5015, 1.42, 0.950, 221, 220, CRYSTAL STRUCTURE OF HIV-1 K103N/Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
282, p6c0oB1, 0.5011, 1.43, 0.945, 221, 220, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
283, p5d3gD1, 0.5010, 1.23, 0.950, 221, 219, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
284, p6c0nB1, 0.5003, 1.47, 0.945, 221, 220, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR 25A 
285, p6c0kB1, 0.5002, 1.28, 0.950, 221, 219, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
286, p5hlfD1, 0.5002, 1.28, 0.950, 221, 219, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
